These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5403099)

  • 41. [Failure of thalidomide treatment in a case of leprous erythema multiforme].
    Duperrat B; Puissant A; Pringuet R; Revuz J; Lauret P; Ghezzi
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(6):736-7. PubMed ID: 5712975
    [No Abstract]   [Full Text] [Related]  

  • 42. [Lampren in the treatment of leprosy].
    Ahrens T
    Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
    [No Abstract]   [Full Text] [Related]  

  • 43. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
    Sheskin J; Mückter H; Frankus E
    Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
    [No Abstract]   [Full Text] [Related]  

  • 44. [Further observations on the use of thalidomide in leprous "reactions"].
    Trimigliozzi G
    G Ital Dermatol Minerva Dermatol; 1967; 108(3):223-8. PubMed ID: 5632577
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment with thalidomide in steroid dependency and neuritis.
    Theophilus S
    Lepr India; 1980 Jul; 52(3):423-8. PubMed ID: 7206639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
    Renders A
    Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
    [No Abstract]   [Full Text] [Related]  

  • 47. Results of a double blind study of the influence of thalidomide on the lepra reaction.
    Sheskin J; Convit J
    Int J Lepr Other Mycobact Dis; 1969; 37(2):135-46. PubMed ID: 4900407
    [No Abstract]   [Full Text] [Related]  

  • 48. Armadillo exposure and Hansen's disease: an epidemiologic survey in southern Texas.
    Bruce S; Schroeder TL; Ellner K; Rubin H; Williams T; Wolf JE
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):223-8. PubMed ID: 10906642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thalidomide in the treatment of lepra reactions.
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):593-7. PubMed ID: 4948095
    [No Abstract]   [Full Text] [Related]  

  • 50. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 51. [Should thalidomide be rehabilitated?].
    Belaube P; Garcin G; Marchand JP; Privat Y
    Sem Hop; 1983 Dec; 59(45):3101-4. PubMed ID: 6320398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Limitations, within narrow indications, in the administration of thalidomide].
    Ned Tijdschr Geneeskd; 1983 Jun; 127(23):1010. PubMed ID: 6877398
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of lepromatous erythema nodosum using chloramphenicol. Comparison with thalidomide. Statistical study from the Marchoux Institute].
    Saint-André P; Ferracci C; Baquillon G; Ridel PR; Boucher P
    Acta Leprol; 1981; (84):57-62. PubMed ID: 6797223
    [No Abstract]   [Full Text] [Related]  

  • 54. Thalidomide reconsidered.
    Nat Biotechnol; 1997 Oct; 15(10):929. PubMed ID: 9335035
    [No Abstract]   [Full Text] [Related]  

  • 55. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
    Magora A; Sheskin J; Sagher F; Gonen B
    Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of Hansen's disease with delayed-action sulfamides].
    Languillon J
    Dermatol Int; 1968; 7(2):84-9. PubMed ID: 5741774
    [No Abstract]   [Full Text] [Related]  

  • 57. A clinical study of thalidomide comparing pre-treatment and post-treatment reactional episodes and corticosteroid requirements.
    Rajan MA; Rajagopalan MS; Joseph M
    Lepr India; 1983 Jan; 55(1):111-6. PubMed ID: 6876752
    [No Abstract]   [Full Text] [Related]  

  • 58. Thalidomide approved.
    Posit Aware; 1998; 9(5):16. PubMed ID: 11365882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine.
    Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH
    Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084
    [No Abstract]   [Full Text] [Related]  

  • 60. [Thalidomide in Brazil: monitoring with shared responsibility?].
    Oliveira MA; Bermudez JA; Souza AC
    Cad Saude Publica; 1999; 15(1):99-112. PubMed ID: 10203451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.